Луций Мацитентан – Купить онлайн

IDR 569,993

2,900+ terjual
Harga Promo

Apotek fisik Hong Kong dengan jaminan produk asli 100%

Keunggulan Produk

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

Jaminan Layanan

Pengiriman Lintas NegaraApotek ResmiDitinjau ApotekerJaminan Keaslian

Spesifikasi

Spesifikasi
10mg*30 tablets
Produsen
Lucius Pharmaceuticals
Pengiriman
Hong Kong

Stok 10000

Informasi Produk

Nama Inggris
Macitentan
Nama Generik
Macitentan

Spesifikasi

Spesifikasi
10mg*30 tablets
Produsen
Lucius Pharmaceuticals
Pengiriman
Hong Kong

Rincian Lengkap

Indikasi

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

Mekanisme Kerja

-1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Farmakologi

12.1 Mekanisme Kerja -1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Interaksi Obat

7.1 CYP3A4 CYP3A4 CYP3A4 [ (12.3)] 7.2 CYP3A4 CYP3A4 HIV CYP3A4

Efek Samping

• - [ Peringatan(5.1)] • [ Peringatan(5.2)] • [ Peringatan(5.3)] • [ Peringatan(5.4)] 6.1 , , 742 SERAPHIN

Package Insert

Indications

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

Efek Samping

• - [ Peringatan(5.1)] • [ Peringatan(5.2)] • [ Peringatan(5.3)] • [ Peringatan(5.4)] 6.1 , , 742 SERAPHIN

Use in Pregnancy and Lactation

8.1 ,OPSUMIT , - , , [ Peringatan] OPSUMIT ERA ,

Interaksi Obat

7.1 CYP3A4 CYP3A4 CYP3A4 [ (12.3)] 7.2 CYP3A4 CYP3A4 HIV CYP3A4

Clinical Pharmacology

12 12.1 Mekanisme Kerja (ET)-1 ET A ET B , (PAH) , ET , , ET-1 ET A ET B ET ET , 20%

Clinical Studies

14 14.1 2 , (PAH) 742 [WHO (FC) II–IV] PAH , (n=250) 3 mg (n=250) 10 mg (n=242), OPSUMIT -5 , 7 “ PAH ” 1 ≥15%

Ulasan Produk (13)

Filter: All Reviews
4.8★★★★★
+o***e· 3 weeks ago
★★★★
+t***3· 1 months ago
Pembelian Terverifikasi
★★★★★

Deskripsi produk

Indikasi

Indicated for pulmonary arterial hypertension (PAH, WHO Group 1) in adults to reduce the risk of disease progression and hospitalization.

Mekanisme Kerja

-1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Farmakologi

12.1 Mekanisme Kerja -1 (ET-1) ETA ETB , (PAH) , , , ET-1 ETA ETB ET

Interaksi Obat

7.1 CYP3A4 CYP3A4 CYP3A4 [ (12.3)] 7.2 CYP3A4 CYP3A4 HIV CYP3A4

Efek Samping

• - [ Peringatan(5.1)] • [ Peringatan(5.2)] • [ Peringatan(5.3)] • [ Peringatan(5.4)] 6.1 , , 742 SERAPHIN